ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,715Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 625

$1.27M Total Retail Price of All Prescriptions

Rank: 8 out of 625

960 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 960 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 960 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

4% of this provider’s 16,531 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 1,123 625 S3 1 4
LEVOTHYROXINE SODIUM 878 714 2 3
AMLODIPINE BESYLATE 784 668 3 1
SIMVASTATIN 731 537 4 2
OMEPRAZOLE 673 442 5 6
PRAVASTATIN SODIUM 566 441 6 8
ZOLPIDEM TARTRATE 395 268 7 13
METOPROLOL TARTRATE 394 304 8 11
FUROSEMIDE 378 288 9 7
ATORVASTATIN CALCIUM 344 248 10 9
HYDROCHLOROTHIAZIDE 340 256 11 12
GABAPENTIN 331 206 12 14
METFORMIN HCL 285 158 13 10
POTASSIUM CHLORIDE 275 213 14 19
METOPROLOL SUCCINATE 270 215 15 15
NEXIUM 267 201 16 21
LISINOPRIL 265 171 17 5
LOSARTAN-HYDROCHLOROTHIAZIDE 263 220 18 38
TRAMADOL HCL 258 152 19 16
LOSARTAN POTASSIUM 255 231 20 18
WARFARIN SODIUM 249 213 21 20
CITALOPRAM HBR 243 155 22 24
SERTRALINE HCL 241 157 23 26
CRESTOR 233 187 24 17
ATENOLOL 211 172 25 22
PANTOPRAZOLE SODIUM 196 124 26 44
AZITHROMYCIN 195 116 27 40
RANITIDINE HCL 189 132 28 25
SYNTHROID 180 157 29 39
ESTRADIOL 179 120 R 30 128
GLIMEPIRIDE 176 109 31 42
CARVEDILOL 169 106 32 23
CIPROFLOXACIN HCL 159 117 33 60
FLUTICASONE PROPIONATE 157 109 34 32
MELOXICAM 157 98 34 31
AMITRIPTYLINE HCL 156 95 R 36 61
TRAZODONE HCL 149 69 37 51
ESCITALOPRAM OXALATE 149 123 37 67
CYMBALTA 148 68 39 46
ALENDRONATE SODIUM 144 114 40 34
PROMETHAZINE HCL 144 34 R 40 84
CLOPIDOGREL 141 95 42 30
CARISOPRODOL 141 17 R 42 89
MIRTAZAPINE 140 101 44 69
SINGULAIR 137 108 45 94
KLOR-CON M20 135 103 46 47
CYCLOBENZAPRINE HCL 132 74 R 47 65
TRIAMTERENE-HCTZ 131 113 48 53
PREDNISONE 130 95 49 37
OXYBUTYNIN CHLORIDE ER 123 86 50 194
FLUOXETINE HCL 121 63 51 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 121 92 51 27
FENTANYL 115 59 S2 53 110
CLONIDINE HCL 114 67 54 50
CELEBREX 114 109 54 72
PREMARIN 113 93 R 56 105
METFORMIN HCL ER 111 86 57 41
DEXILANT 110 82 58 155
PRAMIPEXOLE DIHYDROCHLORIDE 110 89 58 208
FENOFIBRATE 107 78 60 59
BENAZEPRIL HCL 106 63 61 35
MONTELUKAST SODIUM 105 73 62 162
DILTIAZEM ER 101 92 63 121
LOVASTATIN 100 84 64 58
OXYCODONE HCL-ACETAMINOPHEN 100 29 S2 64 87
PLAVIX 98 68 66 43
NAMENDA 98 98 66 45
DONEPEZIL HCL 96 96 68 33
PAROXETINE HCL 95 65 69 76
OXYCODONE-ACETAMINOPHEN 92 66 S2 70 95
ZETIA 92 81 70 66
DIGOXIN 89 81 72 55
PROPRANOLOL HCL 89 62 72 147
LORAZEPAM 85 69 74 171
LIPITOR 85 70 74 75
TAMSULOSIN HCL 85 59 74 36
VENLAFAXINE HCL ER 83 60 77 86
LEVOFLOXACIN 82 52 78 90
BUPROPION XL 82 35 78 180
ISOSORBIDE MONONITRATE ER 82 63 78 49
DIOVAN HCT 80 71 81 52
FELODIPINE ER 78 57 82 156
TOPIRAMATE 78 24 82 243
LANSOPRAZOLE 77 45 84 159
KLOR-CON M10 77 55 84 137
METHYLPREDNISOLONE 77 42 84 120
ALLOPURINOL 77 68 84 29
GLIPIZIDE XL 75 66 88 83
NABUMETONE 75 55 88 179
SPIRIVA 73 32 90 70
JANUVIA 71 37 91 74
LYRICA 70 37 92 71
TIZANIDINE HCL 69 15 93 115
VERAPAMIL ER 68 44 94 103
VENTOLIN HFA 65 33 95 93
TRICOR 64 39 96 118
BUPROPION HCL SR 63 22 97 200
SYMBICORT 63 39 97 123
LEXAPRO 62 48 99 196
PROAIR HFA 62 34 99 57
FLUCONAZOLE 62 36 99 165
LABETALOL HCL 62 43 99 169
BUMETANIDE 61 55 103 178
HYDROXYZINE HCL 58 32 R 104 176
TRAMADOL HCL-ACETAMINOPHEN 58 42 104 144
DIOVAN 58 58 104 28
AMOX TR-POTASSIUM CLAVULANATE 58 30 104 135
VAGIFEM 56 42 108 289
ROPINIROLE HCL 56 33 108 96
DOXYCYCLINE HYCLATE 56 27 108 141
MECLIZINE HCL 54 43 111 113
AMOXICILLIN 54 35 111 132
VESICARE 54 36 111 193
PEN NEEDLE 53 27 114 100
TRIAMTERENE-HYDROCHLOROTHIAZID 52 43 115 174
GLIPIZIDE ER 52 48 115 68
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 7, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.